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SUMMARY
Ficus thonningii has been reported to have
nutritional and ethno-rnedical uses
especially by the Igede-speaking people of
Benne State, Nigeria. Therefore, this study:
was carried out to assess effects of
methanolic.leaf extract of Ficus thonningii
(MEFT) against cholesterol-induced
hyperlipidaemia in rats. Adult rats were
divided into 6 groups of 5 rats each. Group 1
and 2 were orally administered 5
nil/kg/day of distilled water. Groups 3-6
received 10 rug/kg/day of simvastatin, 50,
100 and 200 mg/kg/day of extract
respectively, for 30 days. Cholesterol (400'
mg/kg/ day) was also given to allthe groups
except group 1for 30 days. On day 31, blood
samples were collected for the
determination of serum triglycerides (TG),
total cholesterol (TC), low density
lipoprotein (LDL-c), very low density
lipoprotein (VLDL-c), and high density
lipoprotein (HDL-c). MEFI' (200 rug/kg)
significantly lowered TG, TC, LDL-c and
VLDL-c levels. At this dose the extract also
significantly increased HDL-c levels when
compared with the cholesterol treated
group. These suggest the extract to possess






Tnrecent years much prominence has been
given to the association of abnormal levels
of lipids (e.g. total cholesterol,
triglycerides, LDL and VLDL) with
atherosclerosis and coronary artery
diseases; which are the leading cause of
death (Ross, 1993; Crowther, 2005). The
World Health Organisation (,>\THO)
estimates that every year, 12million people
worldwide die from cardiovascular
diseases, with most of them being from the
developing world (Kmietowicz, 2002).
Hyperlipidaemia is characterized by
elevated serum total cholesterol and low
and very low density lipoprotein
cholesterol and decreased high density
lipoprotein levels. Standard treatment of
dyslipidaemia with statins and other
synthetic agents are available, although not
without side effects (Jerzy and Anna,
2012). Many medicinal plants have been
screened, evaluated and tested against
various cardiovascular diseases including
hyperlipidaemia, still the search is on for
compounds that can safely and effectively
control blood or tissue lipid (triglycerides,
cholesterol, LDL-c) with minimal side
effects.
F. thonningii Blume also known as the wild
fig belongs to the Moraceae family and is
widely used in local medicine for the
treatment of sore throat, colds, diarrhoea,
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jaundice, malaria fever, agalactia and
gonorrhoea (W'att and Breyer, 1962; Ajayi,
2008). It has been observed to posses
analgesic and anti-inflammatory
properties (Otimenyin et aI., 2004),
antimicrobial activity (Ndukwe et al.,
2007), bronchitis and urinary infection
(Cousins and Huffman, 2002), reduced
intestinal motility (Onwkaeme and Udoh,
2000). A survey of 100 households from
two rural-settled groups in Fulani villages,
Northeastern Nigeria, for dietary practices
and the use of edible wild plants showed
that F. thonningii was among those
classified as 'good sources of protein and
fat and excellent sources of calcium and
iron or copper and zinc' (Lockett et aI.,
2000). The leaves of F. thonningii are
prepared as vegetable (cuisine) by tbe
Igede-speaking people of Benue State,
Nigeria (Fadoju et al., 1991; Igoli et al.,
2002). Phytochemical analysis of tile plant
revealed the presence of carbohydrates,
soluble starch, glycosides, steroids,
unsaturated steroids, aglycones, tannins,
saponins, flavonoids, alkaloids, and
anthraquinone glycosides (Trease and
Evans, 1989; Ndukwe et al., 2007). Studies
on the effect of F. thonningii on the serum
lipid level are lacking. Hence, the present
study was carried out to evaluate the effect
of the methanolic extract of F. thonningii
on serum lipid and electrolyte profiles.
UV-2100 Spectrophotometer, US),
analytical weighing balance (Metler-
Toledo GmbH, Greifensee, Switzerland)
and Hammer-mill (Lab mill Type-8,
Christy and Norris Ltd, England). The
different reagents used for the lipid profiles
were procured from Rotche Ltd.
Collection and identification of the plant
material
Fresh leaves of F. thonningii were collected
from Kyado village, Mbazum ward of
Ukum Local Government Area of Benue
State, Nigeria in May, 2009 and identified
by a plant taxonomist in the Department of
Botany, University of Nigeria, Nsukka.
Voucher specimen has been deposited in
the Department's herbarium for reference
purposes.
Preparation and extraction of plant
material
The leaves ofF. thonningii were ail' dried at
room temperature and reduced to powder
by grinding using a Hammer-mill with a 2
mm filter. The powder was stored in an air-
tight container at room temperature until
required for use. The dried powder (500 g)
were measured out and put in a round
bottom flask and exhaustively extracted
with 800 ml of 80% methanol. The
extraction was by cold maceration at room
temperature (2S-280C) with intermittent
shaking at 2 hr intervals for 48 hr.
Whatmall filter paper No 1 was used to
filter the extract at the end of 48 hr. The
filtrate was concentrated in vacuo using
rotary evaporator connected to a cold water
circulator at 400C and 210 milibar yielded





Assay kit for serum calcium, potassium and
sodium were purchased from Teco
Diagnostics, Anaheim, CA.The drugs used
were cholesterol (BDH Chemicals Ltd,
London) and sirnvastatin (Simvor 20®
Ranbaxy, India). All reagent (n-hexane, Experimental animals
methanol and tween 20) used were of All the animals used in this study were
analytical grade. Analytical equipment obtained from a stock bred and maintained
used were rotary evaporator (Buchi, at the animal house ofOlusegun Obansanjo
Germany), autoanalyzer (Hitachi 902, College of Health Sciences, Benue State
Germany), spectrophotometer (UNICO University, Makurdi, Nigeria. The animals
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were kept in plastic cages and acclimatized
for a period of 2 weeks at ambient
temperature and cyclical diurnal changes
in the animal house of the Department of
Veterinary Physiology, Pharmacology and
Biochemistry, College of Veterinary
Medicine, University of Agriculture,
Makurdi, Nigeria. Standard commercial
rat pellets (Vital feed®) prepared byGrand
Cereal and Oil Company (GCOL) Jos,
Nigeria and water were provided ad-
libitum. The laboratory animals were used
in accordance with good laboratory
practice regulation (TOR, 2001) and the
principle of laboratory animal care as
documented by Zimmerman (1983) and
NIH (1985).
Median lethal dose (LDso) estimation of
MEFT
Median lethal dose (LDso) was estimated
using revised up-and-down procedure
(UDP) as described by US EP (1998) and
Gosh (1984). The upper limit test dose of
5000 mg/kg bw was used. Five healthy
female rats (nulliparous and non-
pregnant), aged 10 weeks and weighing
between 118 and 138 g were fasted
overnight before dosing. The limit dose of
5000 rug/kg bw of the methanolic extract
of F. thonningii (MEFr) was administered
to the 1Strat by gavage and the animal was
observed for mortality and other signs of
toxicity for a period of 48 hours following
dosing (with special attention given during
tile first 4 hours) and thereafter for a period
of 14 days. Since the ist animal survived,
four additional animals were sequentially
dosed at approximately 48 hours interval
making a total of 5 animals. The LDso was
predicted to be above 5000 mg/kg bw if
three or more rats survived the test for a
period of 2 weeks.
Experimental procedure
Rats weighing between 100 -150 g were
divided into six (6) groups of five (5)
animals each (n = 5). Group 1 (normal
control) was administered a single dose of
2% tween 20 (5 ml/kg bw p.o), Groups 2-6
were fed a single dose of cholesterol (400
mg/kg bw p.o in 2% w/v tween 20 s.i.d),
Simvastatin (10 mg/kg bw p.o in 2% w]»
tween 20 s.i.d) was given to Group 3
(positive control) 6 hr post cholesterol
administration. Groups 4-6 also received
graded doses (50, 100, and 2(l0 mg/kg bw
p.o in 2% tween 20) ofMEFT respectively 6
hr post-cholesterol administration. All the
treatments lasted for 30 days. The weights
of the all tile animals were taken every
week. At the end of the 30 day treatment
(day 31St), blood samples were collected
from the retro-orbital plexus after an
overnight fast with the help of capillary
tubes into non-anticoagulant test tubes.
Serum total cholesterol (TC), triglycerides
(TG), high density lipoprotein cholesterol
(HDL-c) and low density lipoprotein
cholesterol (LDL-c) were analyzed by using
a Hitachi system 902 automatic analyzer
(Germany). Very low density lipoprotein
cholesterol (VLDL-c) was calculated by
using Friedewald formula (Friedewarld et
al., 1972). Atherogenic index (AI) was
calculated using the formula of Abbot et al.
(1988) and Coronary risk index (CRI) was
calculated by the method of Alladi et al.
(1989). Serum electrolytes (calcium,
potassium and sodium) were determined
by the method of Healy (1995) using
commercial laboratory kits (Teco
Diagnostics, Anaheim, CA).All the animals
were sacrificed using ether and dissected to
collect tile liver, spleen, kidney, heart and
lung for relative organ weight
determination.
Statistical Analyses
The data on body weights, relative organ
weight and biochemical parameters were
analyzed using Statistical Package for
Social Sciences (SPSS) version 16.0 and
expressed as mean±SEM. A test for
significance at 5% level among groups was
performed using One-way Analysis of
958
Ahur et al ISSN 0331 ·3026
Variance (ANOVA). Least significance difference (LSD) post-hoc test was used to detect
significant difference between the treatment and control groups.
RESULTS
Median lethal dose (LDso) determination
The methanolic extract of F. thonningii was found to be non-toxic at the test limit dose of
5000 rug/kg bw p. o. during the 14 days of observation. The LDso of MEFT in rats was
therefore estimated to be above 5000 mg/kg bw.
TABLE I: The effect ofM.EFT leaves on serum rriglycerides, cholesterol, J-(DL·c. L1)L·c and VLDL·c in
h~~rcholesterolelnic-induced rats
Group TGLY TeH (mgldL) HDl·c lDL·c VLDL.., FBS
(mgldL) (mgldL) (mgldL) (mgldL) (mmoIlL)
Nonnal Control 62.8();;4.(,) 44.20±0.97 24.25±1.16 7.39±1.40 12.56±0.81 4.36±0.53
Cholesterol control 160.80±5.47~ 139.60±4.99~ 15.83±1.10~ 91.6O±5.oo~ 32. 16±1.09" 4,26±0.34
Simvastaun control 72.20±3.02' 62,2();;4.45' 27.43±2.87' 20.33±2,73'" 14.440,0,60' 4.340,0.34
MEfT (50 mg/kg) 153,60%6,07" 136.60;1:2.62'" 14,970,0,72" 9O.92±3.23" 30,72± L3 I" 3.48±0.36
MEfT (100 mg/kg) 151.80±5,48M 137.oo±1.51'" 15,050,1.56'" 91.59±Q,85" 30,36±1.10'" 3,44±0,19
MEFT (200 mg/kg) 116.000,3.35'''' 102.00±5.51'" 18.540,1.44" 64.06±5.97'" 23.20±0.67"" 3.46=0.33
Values arc l\'lcal1±SE~IJ11-6. P<O.05 ~sigDiticantly different compared to normal control, =significantly different
compared 10 cbolestercl control, "esignificantly different compared 10 simvastatin comrol.
The effect of ethyl acetate extract of F.
thonningii leaves on serum triglycerides,
cholesterol, HDL-c, LDL-e and VLDL-e in
hypercholesterolemic rats
Hypercholesterolemia was produced in
rats by feeding a high cholesterol diet over a
period of 30 days. Table 1 revealed
significant (P<0.05) increase in serum TG,
TC, LDL-e and VLDL-c and a significant
(P<o.OS) decrease in HDL-c levels in the
hypercholesterolemic-induced rats with
values of 160.80±S.47, 139.60±4.99,
91.60±5.00 and 32.16±1.09 and
15.83±1.10 mg/dL respectively. These
values were significantly different
(P<o.05) in comparison with the normal
control (62.80±4.03, 44.20±0.97,
7.39±lAO and 12.S6±0.81 and 24.25±1.16
mg/dl.). Treatment with MEFf at 50 and
100 rug/kg bw did not produce any
significant (P>o.OS) effects on
hypercholesterolemic animals. But
treatment with MEFr at a dose level of 200
rug/kg bw caused a significant (P<o.05)
reduction in TG, TC, LDL-c and VLDL-c
and further increased serum levels ofHDL-
c significantly (P<0.05). There was no
significant difference between the activity
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Figure 1:The effect oflVlEFf on atherogenic index
(AI) and coronary risk index (eRI) in
hypercholesterolemic-induced rats
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Figure 2: Changes in mean body weight of rats fed










Figure 3: The effect of MEFf on relative organ
weight of hypercbolesterolemic rats (n=s.
a=significantly different compared to tbe
cholesterol control at Pco.os)
Simvastatin at the dose of 10 rug/kg
lowered serum triglycerides, cholesterols,
LDL-cand VLDL-csignificantly but did not
bring them down to baseline values in
comparison with the normal control that
received only the diluent (2% tween 20)
(TABLE I), Table 1also depicts effects of go
days of oral treatment with 400 mg/kg,' day
of cholesterol, 10 mg/kg/day of
simvastatin and 50-200 mg/kg/day of
MEFI' on fasting blood glucose. There was
no significant difference in the values of
FBS among the control and the treatment
groups. However, MEFT at 50-200 mg/kg
showed lower values of FBS compared to
normal, cholesterol and simvastatin
controls, though the differences were not
significant (P>o.Os).
The effect of MEFT on atherogenic
index (AI) and coronary risk index
(CRI) inhypercholesterolemic rats
Hypercholesterolemic-induced rats
without treatment (cholesterol control
group) showed a significant (P<o.OS)
increase in the ratios of LDL-c:HDL-c (AI)
and cholesterol:HDL-c (CRI). Cholesterol
at 400 mg Zkg bw p.o significantly
increased (P<o.OS) the AI and CRI of rats
in the cholesterol control rats. However,
rats treated with MEFT at the dose of 200
rng/kg caused a significant (P<o.OS)
reduction in cardiovascular risks index (i.e,
Al and CRI) of experimental rats (Fig 1).
The results also showed that MEFTat lower
doses (50 and 100 mg/kg bw) did not
reduce the AI and CRI index in
hypercholesterolemic-induced rats .
Effect of MEFI' on mean body weight of
rats fed with high cholesterol diet
Group 1 (normal control) and 3
(simvastatin control) showed relative
constant mean body weights throughout
30 days of experimentation. However,
body weight of control rats decreased in the
first week from 113.0 g to 110.8 g in the
second week of the experimentation and
later increased significantly (P<O.OS) to a
value Ofl24 g in the 4th week (Fig 2). Rats
in group 4 and 5 treated with 50 and 100
mg/kg of MEFT together with high
cholesterol diet showed a progressive mean
body weight gain throughout the 30 days of
experiment. MEFT at 200 mg/kg bw
reversed the progressive increase in mean
body weight from 122.8 gin the jrd week to
114.8gin the 4th week of treatment (Fig 2).
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Effect of MEFT on relative organ weight of
hypercholesterolemic rats
The mean relative weights of spleen,
kidney and lungs were not significantly
different (P>o.Os) among the treatment
and control groups. However, the relative
weight of the liver, significantly increased
(Pco.og) in the cholesterol control group
(4.20±0.i3%) compared to the normal
control (3.30±0.33%) and the sirnvastatin
control (3.38±0.27%). Also, the relative
weight of the heart, significantly increased
(P<0.05) in the cholesterol control group
(0-40±0.02%) compared to the normal
control (O.31±0.03%) and the simvastatin
control (O.32±0.02%). MEFT at 200
rng/kg bw also showed a considerable
reduction of the relative liver and heart
weights (3.02±0.19% and 0.33±0.02%)
similar to the normal and simvastatin
control groups (Fig3).
Effects of MEFT on serum calcium,
potassium and sodium ions of
hyperlipidaemia-induced rats
Serum concentrations of calcium ions were
relatively similar in the all tbe groups
except cholesterol control that have
significantly lower calcium values
compared to the normal and simvastatin
controls (TABLE II). Serum potassium
ions of the animals given MEFT at dose of
200 rng/kg'bw were significantly (Pco.os)
lower compared to the control groups
(TABLEII). However, the differences were
not significant (Pc-o.og) (TABLE II). All
serum concentrations ofsodium ions in the
control groups were similar, but MEFT at
all doses (50, 100 and 200 mg/kg bw)
showed adecrease in sodium ionlevels, but
the difference were also not significant
(Pe-o.og) (TABLEII).
TABLE 2: Effects of McFT on serum calcium, potassium and sodium of
hyperlipidemia-induced rats
Group Ca2+ (mmol/L) K+ (mmol/L) Na+ (mmol/L)
Normal control 2.49±0.10 4.08±0.IS 142.84±4.08
Cholesterol Control 2.22±0.12'c 4.70±0.23 144.96±9.48
Sirnvastatin control 2.47±0.82 4.78±0.38 142.80±7.66
MEFT (SOmg/kg) 2.30±0.OS 4.64±0.28 123.40±9.80
MEFT (100 mg/kg) 2.26±0.07 4.04±0.L9 130.00±9.3S
MEFT (200 mg/kg) 2.3S±0.04 3.22±O.32'bc 124.26±4.96
Values are Mean±SEM, n=6. P<O.OS"=significantly different compared to
normal control, b=significantly different compared to cholesterol control,
c=significal1tly different compared to simvastatin control.
DISCUSSION cells in lipid droplets (Sniderman and
The body supply oflipid energy in the form Cianflone, 1999). Upon demand,
of fatty acids comes from the diet via the intracellular triglycerides and cholesterol
small intestine or through endogenous are hydrolyzed by the action of hormones
fatty acid synthesis, primarily in the liver. sensitive lipase to release free fatty acids in
These dietary fatty acids are esterified to the form of lipoproteins. Lipoproteins are
form triglycerides (TC) (Brites et al., 1998) known to transport cholesterol and
and cholesterol, which are stored by fat triglycerides in the form of chylomicron,
961
Ahur et al ISSN 0331 ,3026
very lowdensity lipoprotein (''LOL-c), low
density lipoprotein (LOL-c) and high
density lipoproteins (HOL-c) (She and
Wang, 1999; Hesser et al., 1979;Mackness
and Durrington, 1995). These fatty acids
are oxidizedduring Kreb'scycleto generate
energy in the liver (Murray et a!., 2006).
Fatty acid oxidation is one of the major
sources of energy utilized by the body for
metabolic purposes. But excessive
consumption of foods rich in fatty acids
might lead to hyperlipidaemia which
predisposes the body to complications of
vascular diseases (Saleh et a!., 1999;
Nakanishi et aI., 2002). Oxidative
modification of LDL-cappears to have an
important role in initiation and
progression of atherogenic changes in
arterial walls especially the aorta
(Esterbauer et a!., 1993). Cardiovascular
diseases have reached an alarming
prevalence rate, and recent researches
have shown that cardiovascular problems
in patients could be reduced with
cholesterol lowering agents (Mahmood et
al., 2010). As a result of severe organ
toxicity from available chemical
therapeutics with hypolipidaemic
properties, herbal medicines in many
countries of the world have become
potential sources of hypolipidaemic drugs
that are less toxic, affordable and readily
available,
In this study, feeding the animals with
cholesterol supplement resulted in
significant (P<o.OS) increase in the levels
of serum triglycerides, cholesterols, LDL-c
and VLDL-c.The same finding has been
made by Demacker et al (1991) where
hypercholesterolemic diet fed to animals
induced production of cholesteryl ester
rich-VLDL-c by the liver and intestine.
There was also reduction in the rate of
cholesterol removal by the hepatic LDL
receptors (Goldstein et al., 1983) resulting
in increased levelsofLDL-cand VLDL-c,In
our study, MEFT at lower doses (so and
100 rug/kg bw) did not exert significant
lipid lowering effect, but at high doses (200
rug/kg bw)was able to improve the levelsof
HDL-c and reduced the levels of
triglycerides, cholesterols, LDL-c and
VLDL-c significantly (Pco.os). In effect,
there was a significant (P<o.OS)reduction
in atherogenic risks (AI, CRI) (Kinosian et
a1., 1994; Hermansen et al., 2003). The
mechanism of action of this lowering of
levels of triglycerides, cholesterols, LDL-c
and \'LDL-c and increased levels of HDL-c
is not known. One of the mechanisms of
reducing the levels of triglycerides, LDL-c
and VLDL-c is by making cholesterol
unavailable since it is used for the synthesis
of these constituents. In effect,
hypolipidaemic agent will inhibit
cholesterol absorption from CIT and also
inhibit the activities of the enzyme, Acyl-
CoAcholesterol acyltransferase (ACAT),a
key enzyme responsible for the
esterification, absorption and synthesis of
cholesterol (Katsuren et al., 2010). This
agent will also be capable of increasing the
levels of HDL-c. HDL-cmay be protective
by reversing cholesterol transport,
inhibiting the oxidation of LDL-cand has
the capacity to neutralized atherogenic
effects of oxidized LDL-c (Wilson, et a!.,
1988). Literature has reported the
hypolipidaemic effects of flavonoids,
alkaloids, s ap o n in s and tannins
(Chapman, 1995). The presence of these
phytochemicals in MEFT (Trease and
Evans, 1989; Ndukwe et a!., 2007) may be
responsible for these observed
pharmacological effects. Flavonoids in
particularly have been shown to possess
hypolipidaemic effects by preventing LDL-
c oxidation, a prerequisite for
hyperlipidaemia (Bangham and Horne,
1962). Saponin is known to elicit serum
cholesterol lowering activity by causing
resin-like action, thereby reducing the
enterohepatic circulation of bile acids
(Topping et al., 1980); in the process, the
conversion of cholesterol to bile acids is
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enhanced in the liver resulting in
concomitant hypocholesterolemia
(Kritchevsky, 1977; Potter et al., 1979).
These phytoconstituents may also have
inhibitory effect on ACAT,by inhibiting the
absorption and storage of metabolic fatty
acids, thereby reducing the levels of plasma
cholesterol and triglycerides levels. This
will ultimately reduce the levels ofVLDL-c
and LDL-c in the liver and further prevent
cardiovascular attacks. Literary works
revealed a dearth of knowledge of F.
thonningii with respect to diabetes
mellitus, therefore a preliminary
assessment of fasting blood sugar (FBS) in
the go day antihyperlipidaernicstudyofthe
plant revealed the plant to lower blood
glucose levels significantly as compared to
the control groups. This result may point to
the antidiabetic property of the plant but
required further validation.
The relative organ weight is very important
in the proper functioning of the organs of
the body. The weight of the organs in the
body increases in direct proportion with
increase in the body weight of the animals.
Tndiseased states, this may not be so. Jn the
analysis of relative organ weight, average
organ weights of spleen, heart, kidney and
lungs at the end of the experiments were
within the normal range. MEFf at 200
rug/kg bw significantly (P<o.OS) inhibited
the liver weight gain induced by high
cholesterol diet compared to cholesterol
control group. This could be suggested that
MEFT might have blocked the
accumulation of fatty acid in the
hepatocytes. Similarly, MEFT (200 mg/kg
bw) significantly reverses the progressive
body weight gain (obese) in the last week of
the experiment to almost the base line
values comparable to the normal and
simvastatin controls. This could be as a
result of the inhibition of cholesterol
absorption from the intestine as
phytochemical analysis of F. thonningii
elucidates the presence of saponins (Trease
and Evans, 1989; Ndukwe et al., 2007).
Saponins are reported to prevent
cholesterol absorption, interfere with its
enterohepatic circulation and increase its
faecal excretion (Chapman, 1995; Purohit
and Vyas, 2006). Again, these hypotheses
would require experimental validation.
However, the prevention of body weight
gain by MEFf at 200 rug/kg bw is in
contrast with the report of Coker et al.
(2009) who reported the weight gain effect
of methanolic extract of F. thonningii. This
could be as a result of the dietary value
(having a crude protein value of 7 g/lookg)
of the plant as reported by Ademosun et al.
(1988) and Bamikoleet al. (2001).
Lockett et al. (2002) reported "chediya" (F.
thonningii) to be an excellent source of
dietary protein, calcium and iron or copper
and zinc; therefore, serum analysis of some
electrolyte showed a significant decrease in
serum calcium (Ca2+) in the group treated
cholesterol alone and also a Significant
decrease in potassium levels of the group
treated MEFT at 200 rug/kg bw. Type of fat
in diet plays an important role on serum
calcium concentration and bone health
(Amr et aI., 2010). Feeding of experimental
rats with high levels of cholesterol diet
resulted in a significant decrease in serum
calcium ions (TABLE II). This finding is in
agreement with the findings of 'Watkin et
al. (1996) who reported that growing
animals fed saturated fat enriched diets
had significantly greater absorption rate of
calcium by bones, increased bone
formation and subsequently low calcium
plasma or serum concentration. Therefore,
low calcium concentration encountered in
our study (cholesterol control group) may
be as a result of increased calcium uptake
by bones induced by hypercholesterolemic
diets. A number of drugs are reported to
increase renal loss of serum potassium
(hypokalaemia) including diuretics (non
potassium sparing), c is p l at in ,
aminoglycosides, amphotericin and
foscarnet and acetazolamide (Crook,
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2006), therefore, the observed
hypokalaemia in the group treated MEFf
(200 mg/kg bw) may be as a result of the
extract inducing renal lost of serum
potassium as the dose increases.
From this study, we can suggest that MEFf
possess hypolipidaemic effects by lowering
serum triglycerides, cholesterol, LDL-c
and VLDL-c, but enhancing HDL-c values
in hypercholesterolemic-induced rats. The
possible mechanism of MEFT on
prevention of hyperlipidaemia may be
related to its ability to prevent oxidation of
LDL-c or inhibition of intestinal
absorption of dietary cholesterol. Further
studies in other animal species and in other
hyperlipidaemic model are required to
elucidate its hypolipidaemic activity.
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